Skip to content

Contrast MDS

Active Private limited companyfounded 2017active for 9 yearsSchoonstraat 123, 9940 EvergemKBO/BCE: BE 0681.789.145

Lifetime

8 annual accounts with figures on one time axis
peak of €101,763 in 2025
€101,763▲ 80.1%
lowest -€66,528 in 2018
€31,256▲ 157%
peak of €58,753 in 2022
€18,600▼ 65.1%
€237,864▼ 10.2%
Board3 names since 2017
3 directors and 2 others
Documentsfilings and deeds
11-08-202611 days late
2025micro format
Gross margin from €56,509 to €101,763Result from €12,139 to €31,256Dividend €66,011Equity from €53,355 to €18,600Cash from €82,029 to €31,416

Key points

from the 2025 annual accounts

Equity

€18,600 ▼ 65.1%
53,3552024+31,256Profit-66,011Dividend18,6002025

Contrast MDS paid out €66,011 in dividends. That is 211% of the 2025 profit.

Turnover

≈ €290,000 estimated

The micro format states no turnover.

Debts

€237,864 93% of the balance sheet
Financial debts 70%Suppliers 2%Taxes and wages 1%Other 27%

Of this, €70,818 falls due within a year.

Liquidity

0.69 was 1.41 in 2024

Short-term debts rose from €69,334 to €70,818.

Filings

8 annual accounts 1 late
AprilJune31 JulyOctober20202025

The 2025 accounts came 11 days late. The other seven were filed on time.

Position in the sector

€31,256

Higher net result than 81% of companies in food and beverage service. The sector median is €4,657, over 18,653 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as Contrast MDS has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for Contrast MDS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 28-09-2017
Director, , since 28-09-2017
Director
  • 929 sharesdeed of 28-09-2017
  • 929 sharesdeed of 28-09-2017
  • 2 sharesdeed of 28-09-2017
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0681789145
1 director appointed, 1 manager resigning, 1 reappointment resigns as manager · reappointed as director · appointed as director · General meeting of 29-03-2023 · Gazette deed
resigns as director Discharge granted to · General meeting of 22-07-2020 · Gazette deed
Registered office moved within Evergem The registered office moved from Ralingen 138, 9940 Evergem to Schoonstraat 123, 9940 Evergem · appointed as manager · General meeting of 22-08-2018 · Gazette deed
All 16 events

Comparable companies

same main activity, similar in size and age
Company
Contrast MDS Evergem €256,464 €101,763 7.3% -
Madam Jeanne Lebbeke €239,205 €105,432 7.5% -
CRO-MAGNON Stekene €241,637 €110,524 18.5% -
't ZAVELHOF Sint-Lievens-Houtem €289,224 €118,556 -82.1% 2.7
Orymaz Antwerp €250,724 €95,670 84.0% 1.3
Gusto26 Antwerp €252,628 €98,066 18.4% -
Le Jardin du Thé Namur €278,362 €97,234 52.9% -

These companies have the same main activity as Contrast MDS: full-service restaurants (NACE 56111). They are comparable in size and age: total assets between €239,000 and €289,000, founded between 2017 and 2018.

Official details

Source: KBO
Status
Active since 26-09-2017Normal situation
Activity
Full-service restaurantsNACE 56111
Establishment unit
2.274.490.7419940 Evergem, since 26-09-2017
Financial year end
31 December
Peppol
Reachable since 31-10-2025
Company details

Annual accounts 2025

€256,464▼ 19.4%
Filing
Filed on 11-08-2026
Financials

Insights on Contrast MDS

Contrast MDS files the micro format. That format states no turnover. The gross margin rose from -€30,685 in 2018 to €101,763 in 2025.

The balance sheet grew most from 2023 to 2024 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Contrast MDS

What is the company number of Contrast MDS?
The company number of Contrast MDS is 0681.789.145. The VAT number is the same number with BE in front: BE 0681.789.145.
Where is Contrast MDS based?
The registered office is at Schoonstraat 123, 9940 Evergem.Company details
What does Contrast MDS do?
According to the KBO register, the main activity is full-service restaurants (NACE 56111).
What is the legal form of Contrast MDS?
Contrast MDS is a private limited company (BV).
When was Contrast MDS founded?
Contrast MDS was founded on 26-09-2017.
Is Contrast MDS still active?
Yes, Contrast MDS is an active enterprise in the KBO register.
What is the turnover of Contrast MDS?
The turnover in financial year 2025 is about €290,000. This figure is estimated from the gross margin of €101,763 and 91 comparable companies (NACE 56111). It probably lies between €250,000 and €360,000.Financials
Is Contrast MDS profitable?
In financial year 2025, Contrast MDS made a profit of €31,256.
Where can I find the annual accounts of Contrast MDS?
Contrast MDS filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Contrast MDS due?
Contrast MDS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.